AB0780 Frequency and characteristics of cancer associated myositis in a cohort of 20 patients with anti-jo-1 positive myositis
A. Meyer(Laboratoire de Physique de Clermont Auvergne), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), J.-E. Gottenberg(Université de Strasbourg), Rose‐Marie Javier(Laboratoire National de Référence), Christelle Sordet, Emmanuel Chatelus(Laboratoire National de Référence), Béatrice Lannes, Bernard Gény(Université de Strasbourg), Arnaud Theulin(Hôpitaux Universitaires de Strasbourg)
Cited by 0
Related Papers
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207